Living longer – and above all staying healthy for longer: longevity research is booming, with billions in investment, new drug candidates and gene therapies. This overview separates evidence from hope and leads you to all Medizin Aktuell articles on the topic.
In short: The best evidence is still for the basics: exercise and strength training, not smoking, good blood pressure, blood sugar and cholesterol levels, enough sleep and social contact. Medicines, gene therapies or plasma exchange “against ageing” have not yet been shown to work in humans – but first trials are under way.
Lifespan and healthspan
Experts distinguish life expectancy (lifespan) from the years spent in good health (healthspan). Research aims above all to extend the healthy years. What a long-term analysis from the USA shows · Growing older does not automatically mean decline
What is proven to help
- Exercise and strength training: lower the risk of cardiovascular disease, diabetes and falls. How much strength training is optimal
- Not smoking – the biggest single lever.
- Knowing and treating risk factors: blood pressure, blood sugar, cholesterol, including the often unknown Lp(a) level.
- Diet: plenty of vegetables, pulses and wholegrains; little highly processed food and red meat. Red meat and diabetes risk
- Sleep, social contact and mental activity.
Measuring biological age
“Epigenetic clocks” estimate biological age from changes to the genome. They are exciting research tools but still imprecise for individuals. Biological clocks put to the test · Which organ ages faster?
Medicines against ageing?
- Weight-loss injections: Does semaglutide slow the biological clock? · Longer life in old mice
- Senolytics (removing “zombie cells”): Where research stands in 2026
- Old medicines, new uses: Network analysis screens 6,400 medicines
- Dogs lead the way: The first longevity drug for dogs
Rejuvenating cells: reprogramming and gene therapy
With certain control genes, cells can be partly “reset” in the laboratory. First trials in humans are starting in easily accessible organs such as the eye.
- Cellular rejuvenation by gene therapy begins in the eye
- Reprogramming against Alzheimer’s
- NewLimit bets on mRNA reprogramming
- FGF21 gene therapy in old mice
- Klotho as an mRNA therapy
More on the methods: Gene therapy and gene editing – an overview.
Blood and plasma
Plasma exchange against ageing? What the first placebo-controlled trial shows
Major research programmes
- XPRIZE Healthspan: 101 million dollars for ten healthy years
- US agency ARPA-H launches the PROSPR ageing programme
Be careful with offers
Many clinics and online shops sell expensive “anti-ageing” infusions, tests or even unapproved gene therapies. Their benefit is unproven and the risks can be considerable. Why experts warn against unregulated offers
Frequently asked questions
Is there a medicine that has been shown to slow ageing?
No, not in humans. Some candidates show signals in animal studies or early trials, but solid evidence of more healthy years is lacking so far.
Is a biological age test worth it?
For individuals the benefit is limited because results fluctuate and no reliable recommendations can be derived from them. Blood pressure, blood tests, fitness and weight are more informative.
What is the most important factor for a long, healthy life?
There is no single factor. The strongest evidence is for not smoking, regular exercise and treating risk factors such as high blood pressure.
German version: Longevity 2026: Was die Forschung zum gesunden Altern wirklich zeigt
This overview is for general information and does not replace medical advice. It is not investment advice. Last updated: November 2026; updated continuously.